Seeing Is Believing
BEAM is currently covered by 14 analysts with an average price target of $55.88. This is a potential upside of $21.92 (64.55%) from yesterday's end of day stock price of $33.96.
Beam Therapeutics 's activity chart (see below) currently has 26 price targets and 50 ratings on display. The stock rating distribution of BEAM is 40.63% HOLD and 59.38% BUY.
Analysts average stock forecasts to be materialized ratio is 41.5% with an average time for these price targets to be met of 84 days.
Highest price target for BEAM is $78, Lowest price target is $30, average price target is $55.88.
Most recent stock forecast was given by KOSTAS BILIOURIS from BMO on 27-Mar-2024. First documented stock forecast 02-Mar-2020.
Currently out of the existing stock ratings of BEAM, 13 are a HOLD (40.63%), 19 are a BUY (59.38%).
Analyst name
Rating
Current price target
Potential distance
Previous price target
Date
Price targets met ratio
Average potential upside
Average Time (Days) For PT To Be Met
Performance score
Buy
57
$23.04 (67.84%)
66
1 days ago
2/4 (50%)
$23.04 (67.84%)
4
Hold
42
$8.04 (23.67%)
26
1 months ago
7/7 (100%)
$-1.61 (-3.69%)
164
Hold
35
$1.04 (3.06%)
42
1 months ago
3/3 (100%)
$-8.61 (-19.74%)
114
Buy
40
$6.04 (17.79%)
75
1 months 28 days ago
3/5 (60%)
$11.71 (41.39%)
237
Buy
66
$32.04 (94.35%)
120
2 months 12 days ago
0/2 (0%)
$40.9 (162.95%)
What is BEAM (Beam Therapeutics ) average time for price targets to be met?
Which analyst has the current highest performing score on BEAM (Beam Therapeutics ) with a proven track record?
Which analyst has the most public recommendations on BEAM (Beam Therapeutics )?
Which analyst is the currently most bullish on BEAM (Beam Therapeutics )?
Which analyst is the currently most reserved on BEAM (Beam Therapeutics )?